Oak Woods Acquisition (OAKUU) Return on Assets ROA from the second quarter of 2025 to second quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket
 


Oak Woods Acquisition Corp  (NASDAQ: OAKUU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Oak Woods Acquisition's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Oak Woods Acquisition's ROA in the second quarter of 2025?
Oak Woods Acquisition Corp achieved a return on average assets (ROA) of 144.14 % in its second quarter of 2025, this is above OAKUU's average return on assets of 73.02%.
Oak Woods Acquisition Corp assets over the 12 months ending in its second quarter of 2025 are valued at $33 million

Despite the company's net income deteriorating, Oak Woods Acquisition was able to improve its ROA compared to the first quarter of 2025.

However, within the Healthcare sector 5 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 43, from total ROA ranking in the first quarter of 2025 at 49.

What is ROA?



Return On Assets (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
Y / Y Total Assets Change -32.26 % -32.9 % 4803.94 % -44.83 % 4.41 %
Y / Y Net Income Change - - - -19.72 % -
Net Income (TTM) in million 47 47 48 48 60
Return On Assets (TTM) 144.14 % 124.88 % 110.71 % 153.55 % 190.34 %
OAKUU's Total Ranking # 43 # 49 # 57 # 70 # 65
Total Assets (TTM) in million 42 41 48 1 62
Seq. Total Assets Change 2.55 % -14.58 % 7541.62 % -98.99 % 1.58 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 0
Sector # 6
Overall # 38

Return On Assets Statistics
High Average Low
96.53 %
73.02 %
0.84 %
(Jun 30 2025)   (Jun 30 2024)





Financial Statements
Oak Woods Acquisition's Assets $ 42 million OAKUU's Balance sheet
Oak Woods Acquisition's Income $ 0 million Quarterly OAKUU's Income Statement
OAKUU's Income by Division See OAKUU's Income by Division



Annual Return On Assets (Sep 30 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023

FY

FY
Y / Y Total Assets Change -9.71 % 4803.94 % - - -
Total Assets in million 43 48 1 0 0
Y / Y Net Income Change -92.75 % -97.8 % - - -
Net Income in million 0 0 9 0 0
Annual Return On Assets 0.03 % 0.4 % 891.44 % - -




Comment on OAKUU's ROA in the fiscal year ending 2025
In the fiscal year 2025 Oak Woods Acquisition's ROA decreased compared to previous year to 0.03 %, due to deterioration of net income -92.75 % to $0.01 million, from $0.19 million a year ago, as OAKUU's assets were $43.35 million.


More Return On Assets Ratios
OAKUU's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OAKUU's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OAKUU's Competitors
Subscribers only: Roa for Oak Woods Acquisition's Suppliers
Subscribers only: Return On Assets for OAKUU's Customers

You may also want to know
OAKUU's Roi OAKUU's Inventory Turnover Ratio OAKUU's Growth Rates OAKUU's Dividend Comparisons
OAKUU's Profitability Ratios OAKUU's Asset Turnover Ratio OAKUU's Dividend Growth
OAKUU's Roe OAKUU's Valuation Ratios OAKUU's Financial Strength Ratios OAKUU's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA
Silexion Therapeutics Corp  286.41 %
Pavmed Inc   172.62 %
Capforce Inc   165.71 %
AnTix Holdings, Inc.  136.27 %
Semnur Pharmaceuticals Inc   131.61 %
Emmis Acquisition Corp   107.50 %
Oak Woods Acquisition Corp  96.53 %
Rigel Pharmaceuticals Inc  57.03 %
Seres Therapeutics Inc   54.88 %
Gridai Technologies Corp  53.25 %
Exelixis Inc   48.25 %
Earth Science Tech Inc   44.59 %
Adma Biologics Inc   42.90 %
Coherus Oncology inc   40.76 %
Entera Bio Ltd   40.32 %
Agios Pharmaceuticals Inc   40.12 %
Abeona Therapeutics Inc   39.81 %
Biomx Inc  39.73 %
Dariohealth Corp   39.03 %
Stablecoin Development Corporation  38.52 %
Interpace Biosciences Inc   37.22 %
Cytomx Therapeutics Inc   36.01 %
Medinotec Inc   35.97 %
Siga Technologies Inc  35.65 %
Edwards Lifesciences Corporation  31.53 %
Synlogic Inc   31.51 %
Minerva Neurosciences Inc   31.37 %
Idexx Laboratories Inc  29.89 %


Date modified: 2026-09-08T15:22:16+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.